1. Home
  2. ANIX vs STIM Comparison

ANIX vs STIM Comparison

Compare ANIX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.90

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
STIM
Founded
1982
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
120.4M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
ANIX
STIM
Price
$2.74
$2.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.67
$3.00
AVG Volume (30 Days)
365.4K
1.2M
Earning Date
05-27-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
57.25
EPS
N/A
N/A
Revenue
$210,000.00
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$0.80
52 Week High
$5.46
$3.44

Technical Indicators

Market Signals
Indicator
ANIX
STIM
Relative Strength Index (RSI) N/A 52.77
Support Level N/A $2.65
Resistance Level N/A $3.25
Average True Range (ATR) 0.00 0.20
MACD 0.00 -0.03
Stochastic Oscillator 0.00 40.56

Price Performance

Historical Comparison
ANIX
STIM

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: